Rare diseases
Investigational molecules
Locations
378 conditions with trials, the busiest first
838 trials across Europe, recruiting first
Study on Anakinra for Patients with Intracerebral Hemorrhage to Reduce Brain Swelling After Stroke
The NetherlandsStudy on Mesenchymal Stem Cells for Patients with Systemic Sclerosis and Digital Ulcers
The NetherlandsStudy on the Effects of Pentoxifylline, Retinol Acetate, and DL-Alpha Tocopherol Acetate for Patients with Medication-Related Osteonecrosis of the Jaw
FranceStudy on the Effects of Fludrocortisone in Treating Neurogenic Orthostatic Hypotension in Patients
FranceStudy on Valsartan for Slowing Aortic Root Dilatation in Children and Young Adults with Marfan Syndrome and Related Conditions
PolandEfficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization
AustriaEfficacy and Safety of Atumelnant, Hydrocortisone and Prednisone in Adults with ACTH‑Dependent Cushing’s Syndrome: A Phase 2/3 Dose‑Finding Study
AustriaEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaA study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.
BelgiumA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
AustriaStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
AustriaStudy of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma
AustriaThe therapies tested most often in Vascular disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
